Sarepta said on Monday that its late-stage study testing two gene-targeted therapies for Duchenne muscular dystrophy did not ...
Opinion
46mon MSNOpinion
AI has real problems. The smart money is investing in the companies solving them now.
AI has real problems. The smart money is investing in the companies solving them now. O penAI’s o3 just cleared artificial general intelligence (AGI) benchmarks. Eighty-seven percent on ARC-AGI, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback